Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFLX.L Regulatory News (FLX)

  • There is currently no data for FLX

Establishment of Cyber Security Capability

17 Apr 2014 07:00

RNS Number : 0266F
Falanx Group Limited
17 April 2014
 



 

FALANX GROUP LIMITED

("Falanx")

 

Establishment of Cyber Security Capability

 

 

In its September 2013 Interim Results, Falanx Group Limited, a security and risk management consultancy working with blue chip and government clients worldwide, stated that its Cyber Security Division was in discussion with several high-quality cyber security providers with a view to the early establishment of a unique set of capabilities that can be offered as a single proposition for the overseas market. Significant progress towards this aim has now been made.

 

Falanx is pleased to announce it has entered into an Agreement with Assuria Limited ("Assuria") for a global licence to use its suite of cyber security software products, as part of Falanx's international cyber security proposition. Assuria is a UK based developer of robust and proven Cyber Security solutions that are used by government agencies, public sector departments and commercial companies worldwide. Assuria's software solutions are developed entirely in-house in the UK, using industry leading technologies, standards and processes.

In parallel Falanx has entered into an agreement with MDS Technologies Limited ("MDS"), a highly successful channel partner of Skyscape Cloud Services Ltd ("Skyscape"). Skyscape is the market leading provider of assured cloud computing services to UK government departments under the G Cloud contracting framework. MDS has specific expertise in providing data centre hosting and services to enable clients to move their computing and IT services into the cloud.

 

MDS is to form a strategic alliance with Falanx to develop new cyber security capabilities that can directly support its business by providing a wider range of security management services for its clients as well as gaining the benefit of Falanx's international network of business contacts.

 

Falanx management team has identified a clear demand within the UK and in its target regions of the Middle East and Asia for comprehensive cloud-based cyber security services. By deploying Assuria's excellent security software alongside an existing high-quality provider of assured cloud computing services, Falanx will be able to provide a seamless and cost-effective suite of services for both government and private clients.

 

John Blamire, CEO of Falanx Group Limited, commented:

 

"The creation of a high-quality cyber security proposition is a central plank of Falanx Group's strategy. We are therefore delighted to have established a relationship with two outstanding companies such as Assuria and MDS to develop a comprehensive cyber security proposition for our clients."

17th April 2014

 

 

For further information contact:

 

Falanx Group Limited

John Blamire, Chief Executive

Tel: 020 7856 9457

www.falanxgroup.com

 

WH Ireland Limited

Nominated Adviser & Joint Broker

Chris Fielding / Nick Field

Tel: 020 7220 1666

 

Peterhouse Corporate Finance

Joint Broker

Jon Levinson / Lucy Williams

Tel: 020 7469 0930

 

Lothbury Financial ServicesMichael Padley / Gary MiddletonTel: 020 3440 7620

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCQKADDOBKDAQD
Date   Source Headline
9th Dec 20222:42 pmRNSHolding(s) in Company
8th Dec 20224:29 pmRNSResult of AGM
8th Dec 20227:00 amRNSInterim Results
24th Nov 20225:17 pmRNSHolding(s) in Company
15th Nov 20225:56 pmRNSNotice of AGM
18th Oct 20227:00 amRNSDirectorate Change
29th Sep 20227:00 amRNSFinal Results
20th Sep 20227:00 amRNSHolding(s) in Company
5th Sep 20224:53 pmRNSHolding(s) in Company
4th Aug 20222:06 pmRNSSecond Price Monitoring Extn
4th Aug 20222:00 pmRNSPrice Monitoring Extension
4th Aug 202211:05 amRNSSecond Price Monitoring Extn
4th Aug 202211:00 amRNSPrice Monitoring Extension
4th Aug 20227:00 amRNSTrading Update
9th May 20227:00 amRNSPartnership to Provide M-EDR to UK Customers
8th Apr 20224:06 pmRNSHolding(s) in Company
6th Apr 202211:59 amRNSHolding(s) in Company
1st Apr 20227:00 amRNSChange of Adviser
30th Mar 20222:44 pmRNSDirector/PDMR Shareholding
23rd Mar 202212:59 pmRNSDirector/PDMR Shareholding
10th Feb 202211:11 amRNSDirector/PDMR Shareholding
24th Jan 20227:00 amRNSDirector/PDMR Shareholding
19th Jan 20225:20 pmRNSHolding(s) in Company
19th Jan 20227:00 amRNSDirector/PDMR Shareholding
7th Dec 202111:14 amRNSResult of AGM
7th Dec 20217:00 amRNSInterim Results
16th Nov 20212:10 pmRNSNotice of AGM
29th Oct 20211:57 pmRNSExercise of Options, TVR and PDMR dealing
27th Oct 20219:03 amRNSDirector/PDMR Shareholding
26th Oct 20217:00 amRNSDirector/PDMR Shareholding
25th Oct 20213:25 pmRNSExercise of Options and TVR
13th Oct 202111:06 amRNSSecond Price Monitoring Extn
13th Oct 202111:00 amRNSPrice Monitoring Extension
13th Oct 20217:00 amRNSTrading update and BOOST&Co loan facility update
6th Oct 20214:41 pmRNSSecond Price Monitoring Extn
6th Oct 20214:35 pmRNSPrice Monitoring Extension
6th Oct 20212:43 pmRNSSale of Assynt for £4.6 million
4th Oct 20217:00 amRNSFalanx Launch Mass Market Security Assessment Tool
29th Sep 20217:00 amRNSAnnual results for the year ended 31 March 2021
18th Aug 20217:01 amRNSGrant of share options
18th Aug 20217:00 amRNSTrading Update & New Loan Facility
9th Jul 20219:07 amRNSHolding(s) in Company
29th Apr 20217:00 amRNSCancellation of unapproved Share Options
1st Apr 20217:00 amRNSIssue of Equity and TVR
26th Feb 20213:31 pmRNSResult of GM
10th Feb 20212:03 pmRNSPublication of Circular & Notice of GM
8th Feb 202111:05 amRNSSecond Price Monitoring Extn
8th Feb 202111:00 amRNSPrice Monitoring Extension
5th Feb 20217:00 amRNSContract Wins and Covid Business Interruption Loan
18th Jan 20212:06 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.